Business Daily Media

The Times Real Estate

.

Biogen and Eisai launch initiatives to help patients with Alzheimer's disease access ADUHELM

  • Written by ACN Newswire - Press Releases

Biogen and Eisai launch initiatives to help patients with Alzheimer's disease access ADUHELM

Cambridge, MA, Jun 8, 2021 - (JCN Newswire) - Following U.S. Food and Drug Administration's (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as the first and only Alzheimer's disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain, Biogen (Nasdaq: BIIB) and Eisai Inc., U.S.

Read more //?#

Why Every Leader Needs a Personal Branding Strategy in 2025

One of the best investments you can make in 2025? Your Personal Brand.In today’s competitive and digitally driven business world, authenticity and...

Prvidr Recognised as an Australian Financial Review Boss Best Place To Work in 2025

Prvidr, a leading subscription, customer lifecycle management and technology company has debuted on this year’s Australian Financial Review BOSS B...

Why Gen Z is most challenging customer

Teleperformance (TP) Business Insights Report Reveals Key Shifts in Consumer Behaviour TP’s Business Insights report  into consumer behaviors and...

Nourish Ingredients and CABIO Biotech: First-ever global commercial scale for precision fermentation fats

In partnership with CABIO Biotech, Nourish Ingredients has achieved a major milestone with the successful completion of our first commercial product...

Bybit’s $1.5B hack: when people, not tech, are the weakest link

On the 21st of February, hackers pulled off what’s being called the biggest digital heist in history and managed to siphon $1.5 billion from the glo...

The top five lessons in leadership from a female CEO

Leadership isn’t about titles or hierarchy. It’s about people. It’s about creating an environment where your team feels supported, aligned with yo...

Sell by LayBy